Stock listing
Hemab Therapeutics Holdings, Inc.
Selected listing: COAG · NASDAQ · USD · US
Hemab Therapeutics Holdings, Inc. (NASDAQ:COAG), Health Technology. Latest release Sep 24, 2026: Hemab Therapeutics Strengthens Board of Directors…
- Ticker
- NASDAQ:COAG
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Hemab Therapeutics Holdings, Inc.
Hemab Therapeutics Holdings, Inc. is a public company traded under the ticker COAG in the American market. Hemab focuses on developing innovative therapies for patients with rare diseases.
Latest news from Hemab Therapeutics Holdings, Inc.
Hemab Therapeutics Strengthens Board of Directors with Appointment of Keli Walbert
September 24, 2026
Hemab Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of HMB-003, an Investigational Therapy for the Management of Heavy Menstrual Bleeding
September 17, 2026
Hemab Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 11, 2026
Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress
July 13, 2026
Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress
July 11, 2026
Research Hemab Therapeutics Holdings, Inc.
Hemab Therapeutics Holdings, Inc. company profile
View the public company page for Hemab Therapeutics Holdings, Inc. on 6ix.
Hemab Therapeutics Holdings, Inc. news
Read company news and market updates connected to Hemab Therapeutics Holdings, Inc..
Hemab Therapeutics Holdings, Inc. investor events
Find investor webinars, events, and replay context for Hemab Therapeutics Holdings, Inc..